Methodology to predict long-term cancer survival from short-term data using Tobacco Cancer Risk and Absolute Cancer Cure models

Physics in Medicine and Biology

Volumn 47, Issue 22, 2002, Pages 3893-3924

  Mould, R F ^a   Lederman, M ^b   Tai, P ^c   Wong, J K M ^a  

^a Royal Marsden Hospital ^*  (Canada)

^b ROYAL MARSDEN HOSPITAL   (United Kingdom)

^c Allan Blair Cancer Centre   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

PATIENT MONITORING; STATISTICAL METHODS; TOBACCO; TUMORS;

SURVIVAL FRACTIONS;

BIOTECHNOLOGY;

ADOLESCENT; ADULT; AGE DISTRIBUTION; AGED; ARTICLE; CALCULATION; CANCER MORTALITY; CANCER RISK; CANCER STAGING; CANCER SURVIVAL; CAUSE OF DEATH; CHILD; CIGARETTE SMOKING; COHORT ANALYSIS; CONTROLLED STUDY; FEMALE; FOLLOW UP; FREQUENCY ANALYSIS; HUMAN; INTERMETHOD COMPARISON; KAPLAN MEIER METHOD; LARYNX CANCER; LUNG CANCER; MAJOR CLINICAL STUDY; MALE; METHODOLOGY; PREDICTION; PRIORITY JOURNAL; SEX DIFFERENCE; STATISTICAL MODEL; SURVIVAL TIME; UNITED KINGDOM; UTERINE CERVIX CANCER; VALIDATION PROCESS; BIOLOGICAL MODEL; DISEASE FREE SURVIVAL; EPIDEMIOLOGY; EVALUATION; LARYNX TUMOR; LUNG TUMOR; MORTALITY; NEOPLASM; PREDICTION AND FORECASTING; RETROSPECTIVE STUDY; RISK ASSESSMENT; RISK FACTOR; SURVIVAL; SURVIVOR; TREATMENT FAILURE; TREATMENT OUTCOME; VALIDATION STUDY;

DISEASE-FREE SURVIVAL; EPIDEMIOLOGIC METHODS; EPIDEMIOLOGIC STUDIES; HUMANS; LARYNGEAL NEOPLASMS; LUNG NEOPLASMS; MODELS, BIOLOGICAL; MODELS, STATISTICAL; NEOPLASMS; PREDICTIVE VALUE OF TESTS; RETROSPECTIVE STUDIES; RISK ASSESSMENT; RISK FACTORS; SURVIVAL ANALYSIS; SURVIVORS; TREATMENT FAILURE; TREATMENT OUTCOME;

EID: 0037153146     PISSN: 00319155     EISSN: None     Source Type: Journal    
DOI: 10.1088/0031-9155/47/22/301     Document Type: Article

References (47)

1. Abramowitz M and Stegun I A 1965 Handbook of Mathematical Functions (New York: Dover) p 932
2. American Cancer Society 2002 Cancer Facts and Figures 2002 (Atlanta: American Cancer Society)
3. Ang K et al 2001 Head and Neck Cancer Committee report of the Radiation Therapy Oncology Group Int. J. Radiat. Oncol. Biol. Phys. 51 (Suppl. 2) 39-43
4. Bebeshko V G, Cheban A K and Obodovsky I 2002 Research Centre of Medical Science of the Ukraine, Kiev, personal communication
5. Berg J W 1965 The distribution of the cancer deaths in time: a survey test of the lognormal model Br. J. Cancer 19 695-711
6. Berkson J and Gage R P 1952 Survival curves for the cancer patients following treatment J. Am. Stat. Assoc. 45 501-15
7. Berkson J, Harrington S W, Clagett O T, Kirklin J W, Dokerty M B and McDonald J R 1957 Mortality and survival in surgically treated cancer of the breast: a statistical summary of some experience of the Mayo Clinic Proc. Staff. Meet. Mayo Clinic 32 645-70
8. Boag J W 1949 Maximum likelihood estimates of the proportion of patients cured by the cancer therapy J. R. Stat. Soc. Series B 11 15-53
9. Brinkley D and Haybittle J L 1975 The curability of the breast Lancet 1 95
10. Brinkley D and Haybittle J L 1984 Long-term survival of women with breast cancer Lancet 1 1118
11. Chester Beatty Research Institute 1974 Serial Abridged Life Tables England and Wales 1841-1970 Part II Interpolated Cohort Life Tables Survival Probability Values to 1, 2, 3, 4, and 5 Years from Each Year of Age from 5 Years to 97 Years (London: Chester Beatty Research Institute, Institute of Cancer Research, Royal Cancer Hospital)
12. Easson E C and Russell M H 1968 The Curability of Cancer in Various Sites (London: Pitman Medical)
13. Gamel J W and Vogel R L 1993 A model of long-term survival following adjuvant therapy for stage 2 breast cancer Br. J. Cancer 68 1167-70
14. Gamel J W, George S L, Stanley W E and Seigler H F 1993 Skin melanoma. Cured fraction and survival time as functions of thickness, site, histologic type, age and sex Cancer 72 1219-23
15. Gamel J W, Vogel R L, Valagussa P and Bonnadonna P 1994 Parametric survival analysis of adjuvant therapy for stage II breast cancer Cancer 74 2483-90
16. Greenwood M 1926 A report on the natural duration of cancer Ministry of Health Reports on Public Health and Medical Subjects 33 (London: His Majesty's Stationery Office)
17. Haybittle J L 1959 The estimation of the proportion of patients cured after treatment for the cancer of the breast Br. J. Radiol. 32 725-33
18. Haybittle J L 1983 What is the cure in cancer? Cancer Treatment: End-Point Evaluation New Horizons in Oncology vol 2, ed B A Stoll (Chichester: Wiley) pp 3-21
19. Haybittle J L 1964 The cured group in series of patients treated for cancer Anglo-German Med. Rev. 2 421-36
20. Ito S, Suzaki K, Tsujii H, Fujieda J and Goro I 1977 An Analysis of survival data of urinary bladder cancer patients after radiotherapy Nippon Igaku Hoshasen Gakkai Zasshi 37 102-7
21. Kaplan E L and Meier P 1958 Non-parametric estimation from incomplete observations J. Am. Stat. Assoc. 53 457-82
22. Lea D E A 1945 The biological assay of carcinogens Cancer Res. 5 633-40
23. Lederman M 1964 The anatomy of cancer with special reference to tumours of the upper air and food passages J. Laryngol. Otol 78 181-208
24. Lederman M 1967 Cancer of the pharynx: a study based on 2,417 cases with special reference to radiation treatment J. Laryngol. Otol 81 151-72
25. Lederman M 1971 Cancer of the larynx: Part I. Natural history in relation to treatment Br. J. Radiol. 44 569-78
26. Lederman M and Mould R F 1968 Radiation treatment of cancer of the pharynx: with special reference to telecobalt therapy Br. J. Radiol. 41 251-74
27. Lederman M, Busby E R and Mould R F 1969 The treatment of tumours of the upper jaw Br. J. Radiol. 42 561-81
28. Maetani S, Tobe T, Hirakawa A, Kashiwara S and Kuromoto S 1980 Parametric survival analysis of gastric cancer patients Cancer 46 1709-16
29. McLaren C E, Brittenham G M and Hasselblad V 1986 Analysis of the volume of red blood cells: Application of the expectation maximisation algorithm to grouped data from the doubly truncated lognormal distribution Biometrics 42 143-58
30. McLaren C E, Wagstaff M, Brittenham G M and Jacobs A 1991 Detection of two-component mixtures of lognormal distributions in grouped, doubly-truncated data: analysis of red blood cell volume distributions Biometrics 47 607-22
31. Mould R F 2000 Chernobyl Record (Bristol: Institute of Physics Publishing) pp 262-78
32. Mould R F and Boag J W 1975 A test of several parametric statistical models for estimating success rate in the treatment of carcinoma cervix uteri 1975 Br. J. Cancer 32 529-50
33. Mould R F, Hearnden T, Palmer M and White G C 1976 Distribution of survival times of 12,000 head and neck cancer patients who died with their disease 1976 Br. J. Cancer 34 180-90
34. Mould R F, Hanham I W F, McSweeney B F D and Myles D R 1987 The lognormal distribution as a fit symptom duration in the range 0-2 years for 26,000 cases Br. J. Cancer 56 687-89
35. Mould R F, Tai P and Wong J K M 2002 Validation of lognormal prediction models for estimating long-term survival rates from short-term follow-up for localised cancer of the prostate patients registered by the USA SEER program Prostate Cancer Review ed G Bruggmoser, R F Mould, P Tai, T P mate (Munich: W Zuckschwerdt Verlag) ch 19
36. Rabbe A 1974 Radiation treatment of cancer of the cervix of the uterus at the Radium Institute in Copenhagen from 1951-54 Acta. Obstet. Gynecol. Scand, Suppl. 30
37. Rutqvist R E 1985 On the utility of the lognormal model for analysis of breast cancer survival in Sweden 1961-1973 Br. J. Cancer 52 875-83
38. Rutqvist R E, Wallgren A and Nilsson B 1984 Is breast cancer a curable disease? A study of 14,731 women with breast cancer from the cancer registry of Norway 1984 Cancer 53 1793-1800
39. Schrek R and Lipson H I 1941 Logarithmic frequency distributions Hum. Biol. 13 1-22
40. Shottenfeld D and Fraumeni J F eds 1996 Cancer Epidemiology and Prevention 2nd edn (New York: Oxford University Press) p 1379
41. Smithers D W, Rigby-Jones P, Galton D A G and Payne P M 1952 Cancer of the breast Br. J. Radiol. Suppl. 4
42. Souchkevitch G 2002 Radiation and Environmental Health, World Health Organisation, Geneva, personal communication
43. Souma W 2002 Physics of personal income xxx.lanl.gov/abs/cond-mat/0202388 Proc. Nihon Keizei Shimbun Inc Workshop (Tokyo, Nov. 2000) ed H Takayasu (Tokyo: Nihon Keizei Shimbun)
44. Surveillance, Epidemiology and End Results [SEER] Program of the National Cancer Institute, Bethesda 2002 http://seer.cancer.gov/
45. Tudway R C and Freundlich H F 1960 The use of a Cobalt-60 beam unit for the treatment of carcinoma of the larynx Br. J. Radiol. 33 98-104
46. Union Internationale Contre le Cancer 1968 T.N.M. Classification of Malignant Tumours (Geneva: UICC)
47. Wood C A P and Boag J W 1950 Researches on the radiotherapy of oral cancer Medical Research Council Special Report Series 267 (London: His Majesty's Stationery Office)